Probiotics have been claimed as a valuable tool to restore the balance in the intestinal
microbiota following a dysbiosis caused by, among other factors, antibiotic therapy. This …

Since 2000, Clostridium difficile infection has increased substantially in both hospital-
acquired and community-acquired diarrhea, not only in North America but also in Europe …

Clostridium difficile infections are a global clinical concern and are one of the leading
causes of nosocomial outbreaks. Preventing these infections has benefited from …

Clostridioides difficile (CD) is a Gram-positive, anaerobic bacterium that is one of the most
common causes of infective diarrhoea worldwide [1]. Among hospitalized patients …

Clostridioides difficile infection (CDI) is a significant worry within healthcare institutions and
the community. It is one of the leading agents causing severe diarrhea worldwide. Effective …

Objective: To review the efficacy, safety, and role of live biotherapeutic products (LBPs) in
the prevention of recurrent Clostridioides difficile infection (rCDI). Data Sources: A literature …

Introduction Strong clinical data demonstrate that inflammatory bowel disease (IBD) is an
independent risk factor for Clostridiodes difficile infection (CDI) and suggest a globally …

The most common cause of antibiotic-associated diarrhea is Clostridium difficile infection
(CDI). Recurrent C. difficile infection (rCDI) often occurs after successful treatment of CDI …

Clostridium difficile infection (CDI) is one of the most common health care–associated
infections in the United States, and there is concern regarding the emergence of community …

Clostridioides difficile infection (CDI) is a common infectious disease that is mainly caused
by antibiotics. Antibiotic therapy is still the dominant treatment for CDI, although it is …